UB Paderborn / Katalog / Suche / in CDI

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial

Respiratory research, 2020-10, Vol.21 (1), p.280-280, Article 280

2020

Link zum Volltext

Verfügbarkeit prüfen

A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.1137-1148

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.2309-2318

2020

Link zum Volltext

Verfügbarkeit prüfen

An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD

International journal of chronic obstructive pulmonary disease, 2019-12, Vol.14, p.2835-2848

2019

Link zum Volltext

Verfügbarkeit prüfen

Observational Real-World Study to Assess Clinical Characteristics and Device Satisfaction in Patients with COPD Treated with Glycopyrrolate/eFlow ® CS

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.1713-1727

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.1215-1226

2021

Link zum Volltext

Verfügbarkeit prüfen

Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.745-755

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT

International journal of chronic obstructive pulmonary disease, 2019, Vol.14, p.479-491

2019

Link zum Volltext

Verfügbarkeit prüfen

Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD

International journal of chronic obstructive pulmonary disease, 2019-03, Vol.14, p.615-629

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD

International journal of chronic obstructive pulmonary disease, 2018-01, Vol.13, p.1483-1494

2018

Link zum Volltext

Verfügbarkeit prüfen

Empirically supported treatments in pediatric psychology: severe feeding problems

Journal of pediatric psychology, 1999-06, Vol.24 (3), p.193-214

Kerwin, M E

1999

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD

International journal of chronic obstructive pulmonary disease, 2018-01, Vol.13, p.1965-1977

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

International journal of chronic obstructive pulmonary disease, 2018-01, Vol.13, p.2917-2929

2018

Link zum Volltext

Verfügbarkeit prüfen

THE COSTS OF EATING: A BEHAVIORAL ECONOMIC ANALYSIS OF FOOD REFUSAL

Journal of applied behavior analysis, 1995, Vol.28 (3), p.245-260

1995

Link zum Volltext

Verfügbarkeit prüfen

Asthma Control with Once-Daily (qd) Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) in Adults and Adolescents with Asthma Previously Stable with Twice-Daily (bid) Budesonide/Formoterol pMDI

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S8-S8

2008

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial

Respiratory medicine, 2014-01, Vol.108 (1), p.41-49

2014

Link zum Volltext

Verfügbarkeit prüfen

C35 ASTHMA THERAPY I: Dose-Ranging Study Of A Fluticasone Propionate Multidose Dry Powder Inhaler In Adolescents And Adults With Asthma Uncontrolled By Noncorticosteroid Asthma Medications

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Link zum Volltext

Verfügbarkeit prüfen

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Efficacy And Safety Of Sun-101/eflow® (nebulized Glycopyrrolate) In Moderate-To-Very-Severe COPD: Results From The Glycopyrrolate For Obstructive Lung Disease Via Electronic Nebulizer (golden) 3 And 4 Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Link zum Volltext

Verfügbarkeit prüfen

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: In-Vitro Characterization Of The Eflow® Closed-System (eflow® Cs) Nebulizer With Glycopyrrolate Inhalation Solution (sun-101)

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Link zum Volltext

Verfügbarkeit prüfen

C49 COPD: TREATMENT: Improvement In Respiratory Symptoms In Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease Patients Treated With Sun-101 (glycopyrrolate/eflow®) - Patient-Reported Outcomes From The Phase 3 Golden Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Link zum Volltext

Verfügbarkeit prüfen

A37 THE SPECTRUM OF COPD: EPIDEMIOLOGY TO OUTCOMES: Patient Device Satisfaction With Eflow Closed System Nebulizer: Results From The Golden-5 Study In Patients With Moderate-To Very-Severe Chronic Obstructive Pulmonary Disease (COPD)

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Link zum Volltext

Verfügbarkeit prüfen

A37 THE SPECTRUM OF COPD: EPIDEMIOLOGY TO OUTCOMES: Health-Related Quality Of Life (hrqol) In Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Sun-101 (glycopyrrolate/eflow®): Findings From The Phase 3 Golden Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Link zum Volltext

Verfügbarkeit prüfen

Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.1939-1956

2021

Link zum Volltext

Verfügbarkeit prüfen

D44 COPD: TREATMENT FROM BRONCHODILATORS TO OTHER PHARMACOLOGICAL INTERVENTIONS: The Effects Of Indacaterol 75 Mg On Lung Function In Patients With Moderate To Severe COPD: A 24-Hour Serial Spirometry Assessment

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Link zum Volltext

Verfügbarkeit prüfen

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Significant And Sustained Bronchodilation With Indacaterol/glycopyrrolate Versus Placebo: Pooled Analysis Of Flight1 And Flight2 Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial

A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy

Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies

An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD

Observational Real-World Study to Assess Clinical Characteristics and Device Satisfaction in Patients with COPD Treated with Glycopyrrolate/eFlow ® CS

Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement

Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT

Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD

Empirically supported treatments in pediatric psychology: severe feeding problems

Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

THE COSTS OF EATING: A BEHAVIORAL ECONOMIC ANALYSIS OF FOOD REFUSAL

Asthma Control with Once-Daily (qd) Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) in Adults and Adolescents with Asthma Previously Stable with Twice-Daily (bid) Budesonide/Formoterol pMDI

Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial

C35 ASTHMA THERAPY I: Dose-Ranging Study Of A Fluticasone Propionate Multidose Dry Powder Inhaler In Adolescents And Adults With Asthma Uncontrolled By Noncorticosteroid Asthma Medications

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Efficacy And Safety Of Sun-101/eflow® (nebulized Glycopyrrolate) In Moderate-To-Very-Severe COPD: Results From The Glycopyrrolate For Obstructive Lung Disease Via Electronic Nebulizer (golden) 3 And 4 Studies

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: In-Vitro Characterization Of The Eflow® Closed-System (eflow® Cs) Nebulizer With Glycopyrrolate Inhalation Solution (sun-101)

C49 COPD: TREATMENT: Improvement In Respiratory Symptoms In Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease Patients Treated With Sun-101 (glycopyrrolate/eflow®) - Patient-Reported Outcomes From The Phase 3 Golden Studies

A37 THE SPECTRUM OF COPD: EPIDEMIOLOGY TO OUTCOMES: Patient Device Satisfaction With Eflow Closed System Nebulizer: Results From The Golden-5 Study In Patients With Moderate-To Very-Severe Chronic Obstructive Pulmonary Disease (COPD)

A37 THE SPECTRUM OF COPD: EPIDEMIOLOGY TO OUTCOMES: Health-Related Quality Of Life (hrqol) In Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Sun-101 (glycopyrrolate/eflow®): Findings From The Phase 3 Golden Studies

Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial

D44 COPD: TREATMENT FROM BRONCHODILATORS TO OTHER PHARMACOLOGICAL INTERVENTIONS: The Effects Of Indacaterol 75 Mg On Lung Function In Patients With Moderate To Severe COPD: A 24-Hour Serial Spirometry Assessment

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Significant And Sustained Bronchodilation With Indacaterol/glycopyrrolate Versus Placebo: Pooled Analysis Of Flight1 And Flight2 Studies

Suchergebnisse filtern